Alzheimer's Disease Market Research Reports & Industry Analysis
A gradual loss of neurons later in adulthood does not result in significant alteration in brain function during the usual life span. However, the older one gets, the greater the neurologic impairment. Excessive neuronal degeneration in adulthood is called Alzheimer’s disease or senile dementia and is distinguished from the normal changes in aging. Alzheimer’s disease is a progressive disease which results in death of the brain cells causing memory lapses, behavioral issues, and disruption of thinking processes. The disease is considered fatal. Age and generic inheritance are the two key risk factors for developing Alzheimer’s disease. These are also risk factors that are not preventable. However, other preventable risk factors have been linked to the development of AD, including environment, diet, and overall general health. A combination of risk factors is often responsible for the disease.
Alzheimer’s disease is estimated to affect up to 6% of the population over 65. Life expectancy has been increasing around the world due to advances in healthcare, medical research, sanitation, and nutrition. This provides a setting for a higher number of Alzheimer’s disease patients in the future as the population continues to add years to their life.
Alzheimer's Disease Industry Research & Market Reports
-
Global Alzheimer’s Disease Diagnostics Market Size Study, by Diagnostic Technique (Biomarkers, Imaging Techniques, Genetic Testing), by Type (Triage, Diagnosis, Screening), by End-Use, and Regional Forecasts 2022-2032
... disease escalating at an alarming rate, the urgency for early and precise diagnostics has surged dramatically. Advanced diagnostic techniques leveraging biomarkers, imaging technologies, and genetic testing have revolutionized disease detection, enabling early intervention and paving ... Read More
-
Medical Marijuana Market Size, Share, and Outlook, 2025 Report- By Product (Flower, Oil & Tinctures ), By Application (Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Marijuana segments across 22 countries from 2021 to 2032. ... Read More
-
Medical Foods Market Size, Share, and Outlook, 2025 Report- By Route of Administration (Oral, Enteral), By Product (Powder, Pills, Liquid, Other), By Application (Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases, Wound Healing, Chronic Diarrhea, Constipation Relief, Protein Booster, Dysphagia, Pain Management, Parkinson's Disease, Epilepsy, Severe Protein Allergy, Cancer, Cachexia, Others), By Sales Channel (Online Sales, Retail Sales, Institutional Sales), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Foods segments across 22 countries from 2021 to 2032. ... Read More
-
Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurological Biomarkers segments across 22 countries from 2021 to 2032. ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics Application, Research Application), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Immunoassay for Neurological Biomarkers ... Read More
-
Alzheimer Disease Drugs Markets in China
... growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, ... Read More
-
Alzheimer Disease Drugs Industry Forecasts - China Focus
... in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market ... Read More
-
Alzheimer Disease Drugs Companies in China
... rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s ... Read More
-
NEUROTECHNOLOGY MARKET - GROWTH, TRENDS, AND FORECASTS (2025 - 2030)
... are driving the growth of the neuroelectronics market include the increasing prevalence of neurological disorders, rapid advancements in neuroscience and technology, and the rising demand for improved treatment options. The rising incidence of neurological disorders, ... Read More
-
Alzheimer's Drugs Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Global Alzheimer's Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
... CAGR of %during review period. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. ... Read More
-
Early Diagnosis Kit For Alzheimer's Disease Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
... in diagnostic technologies, and rising awareness about early detection. Alzheimer's disease, a progressive neurodegenerative disorder, affects millions worldwide, with an estimated 50 million people living with dementia globally in 2025, a number projected to reach ... Read More
-
Medical Foods Global Market Report 2025 Including: 1) By Type: Pills; Powder 2) By Application: Alzheimer's Disease; Diabetic Neuropathy; Nutritional Deficiency; ADHD 3) By Sales Channel: Retail Sales; Online Sales; Institutional Sales Covering: Nestlé SA; Danone SA; Fresenius Kabi AG; Mead Johnson & Company LLC; Primus Pharmaceuticals Inc.
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Alzheimer’s Disease Drugs
... at a CAGR of 5.6% over the analysis period 2024-2030. Donepezil Drugs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$5.2 Billion by the end of ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 8.3% CAGR ... Read More
-
Global Early Diagnosis Kit For Alzheimer's Disease Market Growth 2025-2031
... 8.6% from 2025 to 2031. Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects the brain, leading to cognitive decline and memory loss. It is the most common cause of dementia, a syndrome characterized ... Read More
-
Global Early Diagnosis Kit For Alzheimer's Disease Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
... 205 million by 2031 with a CAGR of 8.1% during review period. Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects the brain, leading to cognitive decline and memory loss. It is the most ... Read More
-
Global Early Diagnosis Kit For Alzheimer＇s Disease Competitive Landscape Professional Research Report 2025
... imaging techniques like MRI or PET scans to examine brain structure and function, and biomarker analysis to measure levels of proteins associated with Alzheimer＇s, such as beta-amyloid and tau. The kit may also incorporate genetic ... Read More
-
Global Alzheimer＇s Disease Drug Competitive Landscape Professional Research Report 2025
... and behavior. These drugs are designed to improve cognitive function, slow down the progression of the disease, and manage the symptoms associated with it. Some common Alzheimer＇s disease drugs include cholinesterase inhibitors like donepezil, rivastigmine, ... Read More
-
Precision Psychiatry Market Report by Product Type (Products, Services), Sample (Blood-Based, Non-Blood-Based), Biomarker Type (Genetic Biomarker, Protein Biomarker), Technology (Sequencing, Polymerase Chain Reaction (PCR), Microarray, Immunoassay, Liquid Chromatography-Mass Spectrometry (LC-MS), and Others), Application (Alzheimer’s Disease, Parkinson’s Disease, Autism, Depression, Bipolar Disease, and Others), End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutions, and Others), and Region 2025-2033
... Parkinson’s Disease, Autism, Depression, Bipolar Disease, and Others), End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutions, and Others), and Region 2025-2033 The global precision psychiatry market size reached USD 1,224 Million in 2024. ... Read More
-
Global Alzheimer's Drugs Market Growth 2025-2031
... %from 2025 to 2031. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For ... Read More
-
2025 Global Forecast for Alzheimer'S Disease Diagnostic Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Transcranial Magnetic Stimulation System Market Assessment, By Type [Deep Transcranial Magnetic Stimulation, Repetitive Transcranial Magnetic Stimulation, Others], By Application [Epilepsy, Depression, Alzheimer’s disease, Parkinson’s disease, Others], By Age Group [Children, Adults], By End-user [Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others], By Region, Opportunities and Forecast, 2018-2032F
... Ambulatory Surgical Centers, Diagnostic Centers, Others], By Region, Opportunities and Forecast, 2018-2032F Global transcranial magnetic stimulation system market is projected to witness a CAGR of 10.05% during the forecast period 2025-2032, growing from USD 1.51 ... Read More
-
2025 Global Forecast for Alzheimer'S Disease Drug Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
Alzheimer's Disease Diagnostics & Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... and Africa) The global Alzheimer’s disease diagnostics and treatment market is poised for significant growth, propelled by technological breakthroughs, increasing awareness initiatives, and the rising prevalence of Alzheimer’s disease globally. With an anticipated compound annual ... Read More
Research Assistance
